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Objectives: Reports of improved ejection fraction, coupled with decreased 
filling pressures, have prompted a number of centers to begin evaluating 
the efficacy of heart reduction surgery to ameliorate symptoms of heart 
failure. However, the impact of this operation on cardiac mechanics is 
unknown. We applied a multiple compartment elastance model to simulate 
the effects of excising cardiac mass on heart function. Methods: The left 
ventricle was divided into two functional compartments to simulate excision 
of part of the wall. At multiple increments of mass reduction, the resulting 
end-systolic elastance, ejection fraction, stroke volume, end-diastolic pres- 
sure and volume, and diastolic stiffness were determined. Results: Changes 
in systolic function were accompanied by offsetting changes in diastolic 
function; consequently, overall pump function (the Frank-Starling Rela- 
tionship) was found to be depressed. The geometric rearrangement asso- 
ciated with this operation leads to a reduction in wall stress for a given level 
of pressure generation, thus implying an increase in the efficiency with 
which wall stress is transduced into intraventricular pressure. Conclusions: 
Overall pump function is depressed in the short run after heart reduction 
surgery. However, on the basis of theoretic arguments, heart reduction 
surgery may have long-term beneficial implications. Importantly, this 
analysis revealed that changes in parameters of ventricular function have 
different implications during heart reduction surgery than when such 
changes are observed with inotropism caused by acute pharmacologic 
therapy. (J Thorac Cardiovasc Surg 1997;113:1032-40) 
H eart reduction surgery has been recently intro- duced as a treatment for end-stage dilated car- 
diomyopathy. Considerable interest in this proce- 
dure has been generated by reports of clinical 
improvement in a number of patients after this 
operation. 1 Reports of improved ejection fraction. 
coupled with decreased filling pressures, have 
prompted a number of centers to begin evaluating 
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the efficacy of hearl reduction surgery to ameliorate 
symptoms of heart failure. However. little is known 
about the effects of this procedure on cardiac me- 
chanics; moreover, the significance of changes in 
cardiac mechanics resulting from mass reduction on 
overall pump performance is unclear. 
Ordinarily, evaluation of a therapy like heart 
reduction surgery would be facilitated through the 
use of experimental models. However, lack of an 
appropriate animal model may limit opportunities 
to obtain clinically relevant experimental data. Fur- 
thermore, in the clinical setting it is difficult to make 
the necessary measurements that are required for a 
full understanding of the impact of this procedure 
on cardiovascular function. As a consequence, inter- 
pretation of the available data may be limited. For 
example, while improvement in ejection fraction 
under norman circumstances would generally signify 
improvements in myocardial contractile state and 
pump function, this may not be the case under 
conditions of surgically altered ventricular mass. 
Major advances have been made in understanding 
the relationship between intrinsic myocardial con- 
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tractile properties, muscle mass, and global ventric- 
ular pump function. Through the use of pressure- 
volume and stress-strain analyses, it is possible to 
characterize and predict detailed aspects of cardio- 
vascular dynamics under a variety of conditions. We 
therefore used these analytic tools to derive insights 
into the hemodynamic consequences of heart reduc- 
tion surgery. Particular attention was given to pre- 
dicting the effects on end-systolic and end-diastolic 
pressure-volume r lations (ESPVRs and EDPVRs) ,  
stress-strain relations, ejection fraction, and overall 
pump performance (Frank-Starling relationship). 
The limitations and potential clinical implications 
are discussed. 
Methods and materials 
Overview of cardiovascular model. The cardiovascular 
system was modeled as described previously. 2-4 In brief, 
the dynamics of right (RV) and left ventricular (LV) 
contraction were represented individually by modified 
nonlinear time-varying elastance models that interrelate 
instantaneous ventricular pressures and volumes: 
P(V,t) = (Pes[V]-Pea[V] e[t]) + P~d(V) (1) 
where Pes(V) is a function that describes the ESPVR, 
Ped(V) is a function that describes the EDPVR, and e(t) 
is a function that describes the time course with which 
myocardial properties vary between end-diastole and end- 
systole. These functions are as follows2-4: 
e(t) = 0.5 (sin [m/T,, - 7r/2] + 1) 
e(t) = 0.5 exp ([t - 3Te/2]/t) 
fort < 3T j2  (2) 
for t -< 3Tes/2 (3) 
(4) 
(5) 
Pes(V) = E,.,(V - Vo) 
P,d(V) = A(exp[K (V -  Vo)] - 1) 
where Tes is the time to end-systole, E~s is the end-systolic 
elastance, Vo is the unstressed ventricular volume, A is a 
scaling factor, and K is the diastolic stiffness coefficient. 
With this representation, ventricular chamber contractility 
is indexed by end-systolic elastance. 5 The algorithm for 
coupling the ventricles to the systemic and pulmonary 
vascular systems is detailed in the appendix. 
Heart reduction. To simulate mass reduction surgery, 
we made the following assumptions: the LV wall was of 
uniform thickness, muscle properties were homogeneous, 
and the chamber was rotationally symmetric; we also 
assumed that RV chamber properties were unaffected by 
the ventricular resection. The LV chamber was function- 
atly divided into two compartments, one of which repre- 
sents the portion to be removed (as shown schematically 
in Fig. 1). If the fraction of total LV volume contained 
within the compartment to be removed is defined as r, 





Fig. 1. To simulate mass reduction surgery, the total 
heart, represented by a modified nonlinear time-varying 
elastance (E,ot[t,v]), was functionally divided into two 
portions: the portion to be excised (Ex[t,v]) and the 
portion that is not excised (E,x[t,v]). Details of the 
computations are provided in the text (equations 1 to 6). 
volume of the nonexcised compartment (Pnx[V,t]) relates 
to equation 1 as follows: 
P~(V,t) = P(V/[1 - r], t) (6) 
The amount of muscle removed (Mx) varies with r as 
detailed in the appendix. Mass reduction was assumed to 
reduce LV chamber volume while leaving baseline wall 
thickness unchanged. 
To ensure that the findings based on this multicompart- 
mental model are not unique to this approach, we also 
performed a simple finite element analysis that allowed 
for prediction of ESPVR and EDPVR from specified 
elemental myocardial properties assuming a hemielliptic 
ventricular geometry. Details are presented in the appen- 
dix. 
Protocol. The value of r was varied to achieve mass 
reductions of 25, 50, and 75 gm of myocardium. At each 
value of r, we determined the resulting end-systolic elas- 
tance, ejection fraction, stroke volume, stroke work, LV 
end-diastolic pressure (LVEDP), the diastolic stiffness 
coefficient (K) of the EDPVR, and LV end-diastolic 
volume (LVEDV). Under each mass condition, hemody- 
namic data were also determined at several different 
preload conditions to examine the impact of mass reduc- 
tion on LV pressure-volume r lations, stroke work- 
LVEDV relations (preload recruitable stroke work), 
stroke volume-LVEDP relations (Frank-Starling curves), 
and myocardial stress and strain. Thus, with the exception 
of LV mass and intravascular volume, all parameter 
values were maintained constant for the entire analysis. 
Results 
ESPVRs, EDPVRs,  and their corresponding 
pressure-volume loops obtained in the baseline 
heart failure state and after the three degrees of 
mass reduction are shown in Fig. 2. This figure 
reveals that each increment of mass reduction was 
associated with a leftward shift in ESPVR and 
EDPVR;  the magnitude of the volume-axis hifts 
were identical for both relations. These same shifts 
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Fig. 2. Left ventricular pressure-volume loops (LVP and LW)  are shown at each of the four tevels of mass 
reduction (0, 25, 50, and 75 gm of tissue removed). The pressure-volume loops shift to the left in response 
to mass reduction. Also shown on this graph are the ESPVRs (straight lines that intersect the end-systolic 
point of the respective pressure-volume loop) and the EDPVRs (curvilinear relations that intersect the 
end-diastolic point of the respective pressure-volume loop). As mass is reduced from 0 to 75 gm (solid line, 
dotted line, dashed line, dotted/dashed line), the ESPVR slope increases, and the curvature of the EDPVR 






25 t O 
50,, / 
75 t / / 
, t / 
f l • 
t t / 
1 ,, / 
• t ; 
/ ; / 
' t f 
! t / 
t ! / 
• ! / 
,t it f 
,/t' "i / 
I / ,f/ 
// / /  
I* t f 
I I I 
100 200 300 
EDV (ml) 
F ig .  3,  Leftventricularstrokework-end-diastolicvolume 
relations (SW and EDV). Similar to the ESPVR, the slope 
increases and volume-axis ntercept decreases with incre- 
mental reductions in ventricular mass (0 gm, solid line; 25 
gm, dotted line; 50 gin, dashed line; 75 gm, dotted/dashed 
line). 
in pressure-volume r lations were also found with 
the finite-element analysis described in the appendix 
(Appendix Fig. 1). The pressure-volume loops 
shifted, correspondingly, with little change in filling 
pressure, stroke volume, peak systolic pressure, or 
overall loop shape. The stroke work-LVEDP rela- 
tion derived from these loops is shown in Fig. 3 and 
an increase in slope in response to mass reduction 
reflecting increased systolic chamber function. The 
hemodynamic variables derived from these loops as 
a function of mass removed are shown in Fig. 4. 
Mass reduction caused increases in end-systolic elas- 
tance and ejection fraction (panel A) ,  decreases in 
LVEDV (panel B), and increases in diastolic cham- 
ber stiffness (K, panel B). 
The effect of mass reduction on overall pump 
function was assessed by the relation between filling 
pressure and stroke volume, as shown in Fig. 5. 
These Frank-Starling curves, which exhibited the 
typical exponential rise to a plateau, moved down- 
ward and rightward in response to mass reduction 
indicating a slight reduction in pump performance. 
To understand how mass reduction affects the 
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Fig. 4. A, Slope of the end-systolic pressure-volume relation (Ees;filled squares) and ejection fraction (EF; 
open circles) as a function of amount of LV mass excised (x-axis). Both of these indices of systolic function 
increase with mass reduction. B, Left ventricular end-diastolic volume (LV EDV; filled circles) and the 
stiffness coefficient of the end-diastolic pressure-volume relation (K," open squares) also as a function of LV 
mass excised. Both of these measures reflect he decrease in chamber compliance associated with mass 
reduction. 
mechanical stresses to which the myocardium is 
exposed, we converted the pressure-volume loops of 
Fig. 2 to stress-strain loops, as shown in Fig. 6. 
Myocardial stresses and strains (o- and e, respec- 
tively) were calculated according to the following 
standard equations6: 
o -= 1.355 Pcv(1 + [3Vcv/Vm]) (7) 
e = 1/3 ([In(1 + [3VLv/Vm])]- 
[In(1 + [3Vo/Vm])]) (8) 
where PLY and VLv are instantaneous LV pressure 
and volume, respectively, Vo is the volume-axis 
intercept of the EDPVR, and Vm is the volume of 
the myocardium (0.96 LV mass). With each reduc- 
tion in mass, there was a reduction in peak stress 
along with an increase in loop width (increased 
shortening). These changes indicate that mass re- 
duction is associated with a decrease in myocardial 
afterload stress. 
To more closely examine the impact of mass 
reduction on myocardial afterload stress, we deter- 
mined the relationship between peak pressure and 
peak stress over a range of preloading conditions 
(Fig. 7). At any ventricular pressure, mass reduction 
resulted in a decrease in ventricular stress. This 
analysis highlights the improved efficiency of trans- 
ducing wall stress to chamber pressure after mass 
reduction. 
Discuss ion  
Although heart reduction surgery is now being 
performed at several centers, little is known about 
the impact of this procedure on either intrinsic heart 
function or overall cardiovascular hemodynamics. 
The potential for gaining further insights through 
experimental work is limited by the current lack of 
suitable animal models in which this procedure can 
be studied; furthermore, measurements hat can 
typically be made in the clinical setting may provide 
only limited information about the underlying phys- 
iology. Accordingly, it would be beneficial to take 
advantage of any available techniques that may 
provide such insight. 
Over the past 20 years, pressure-volume relation- 
ships and the time-varying elastance theory have 
evolved as relatively simple approaches to explain- 
ing the dynamics of ventricular contraction and 
ventrieular-vascular interactions under a variety of 
physiologic and pathophysiologic conditions] Expe- 
rience has shown that use of these approaches can 
prospectively lead to important understanding of
1036 Dickstein et al. 
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Fig. 5. Frank-Starling relationship relating stroke volume 
to LVEDP at the four mass reduction conditions (0 to 75 
gm of tissue excision). Notice that mass reduction is 
associated with a downward shift of the Frank-Starling 
curves, indicating a reduction in pump function. 
fundamental physiologic cardiovascular concepts. 
Specific examples that are pertinent o the present 
investigation are the successful use of so-called 
multicompartment models of the LV chamber (i.e., 
functionally dividing the heart into different com- 
partments) to predict pump properties in the face of 
regional ischemia s and abnormal activation se- 
quences 9,10 and to explain interventricular interac- 
tions.i], 3 In a similar vein, we mimicked the situa- 
tion of heart reduction surgery applied to hearts 
with idiopathic dilated cardiomyopathy b  function- 
ally dividing the entire ventricular elastance into a 
portion to be removed and a portion to be retained; 
although this approach has limitations (discussed 
below), our analysis has provided potentially impor- 
tant insights. 
Reports of preliminary clinical experiences sug- 
gest that an early effect of mass reduction surgery is 
in improvement in ejection fraction. This phenom- 
enon was readily predicted by the present analysis. 
In addition, there was an increase in end-systolic 
elastance and preload recruitable stroke work, 
load-independent indices of chamber contractile 
strength. Although these changes ordinarily signify 
significant improvements of ventricular perfor- 
mance, they may not have the same clinical or 
physiologic meaning after mass reduction as they do 
in other acute settings. For example, acutely im- 
proved indices of chamber contractility seen with 
/3-agonist herapy normally signify an increase in 
myocardial contractility. In contrast, improvements 
in these indices after mass reduction are based on 
geometric rearrangement with no effect on underly- 
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Fig. 6. Left ventricular stress-strain loops at each of the 
four levels of mass reduction (0 gin, solid line; 25 gm, 
dotted line; 50 gm, dashed line," 75 gin, dotted/dashed line). 
With mass reduction, there is a decrease in the peak stress 
attained, a small leftward shift of the relations, and a 
widening of the loops. 
ing myocardial function. Furthermore, the improved 
ejection fraction was due to a decrease in end- 
diastolic volume with little change in stroke volume; 
the implications are different from those of a phar- 
macologically induced increase in ejection fraction, 
which is associated with increased stroke volume 
with relatively fixed end-diastolic volume. Finally, 
and also in sharp contrast to pharmacologically 
induced inotropism, improvements in systolic func- 
tion indices seen with mass reduction are accompa- 
nied by counteracting changes in diastolic proper- 
ties. As a result, indices of overall pump function 
such as provided by the Frank-Starling relationship 
are affected in a negative way by mass reduction; 
predicted shifts in this relationship, although small 
in magnitude, are comparable with those that would 
ordinarily be associated with a slight negative ino- 
tropic agent. Thus the balanced effect of mass 
reduction on systolic and diastolic properties con- 
founds interpretation of an increased ejection frac- 
tion, end-systolic elastance, and preload recruitable 
stroke work; increases in these indices are usually 
associated with improved pump function, but this 
does not appear to be the case following mass 
reduction surgery. 
In addition to these acute effects on global hemo- 
dynamics, mass reduction had a significant effect on 
the mechanical stress experienced by the myocar- 
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dium. Specifically, for any given systolic pressure, a
decrease in stress occurred. Consistent with the 
increase in ejection fraction, there was also an 
increase in myocardial shortening (i.e., in the 
change in strain during a beat) despite the relatively 
little change in stroke volume. Thus mass reduction 
causes acute myocardial afterload stress reduction 
by a mechanism that is fundamentally different from 
that normally seen with pharmacologic afterload 
reduction therapy. The latter is typically mediated 
by a reduction in arterial vascular esistance and is 
also associated with an increase in stroke volume 
and decrease in blood pressure. The implications of 
decreased afterload stress after mass reduction have 
several potentially important implications. First, 
myocardial hypertrophy in heart failure is generally 
believed to occur in response to the increased wall 
s t ress .  12 Myocardial hypertrophy may of itself con- 
tribute to contractile dysfunction above that result- 
ing from the underlying myopathy. ~3-15 Reduction of 
wall stress may therefore lead to regression I of 
hypertrophy, which could potentially translate into a 
clinical benefit. However, such an effect could not be 
acute, since regression of hypertrophy would occur 
over weeks to months after the intervention pro- 
vided that this afterload reduction was sustained. 
On the other hand, acute reductions in wall stress 
could also act to reduce subendocardial ischemia, 
which has been hypothesized to contribute to con- 
tractile dysfunction i many forms of cardiomyopa- 
thy. 
One additional effect hat has been observed after 
mass reduction surgery is a decrease in pulmonary 
capillary wedge pressure. However, a decrease in 
left ventricular filling pressure was not predicted by 
the present analysis. It is important to note that the 
present analysis imulated the effects of the mass 
reduction in the absence of other confounding fac- 
tors that may be associated with this surgical proce- 
dure. First, mitral annuloplasty is often performed 
in concert with the mass reduction because of 
acutely altered geometry on mitral valve function 
along with the high incidence of significant mitral 
regurgitation i this patient population. Reduced 
regurgitant volume will decrease pulmonary wedge 
pressures, as well as contribute to an increase in 
forward stroke volume. It is important hat the 
contribution of mitral annuloplasty o the potential 
clinical benefits observed after this procedure be 
clarified. Second, perioperative fluid management 
(including during cardiopulmonary b pass) and va- 
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Fig. 7. Peak stress is shown as a function of peak cham- 
ber pressure at each of the four levels of mass reduction. 
These relations hift downward in response to mass 
reduction. The implication is that stress is reduced at a 
given peak chamber as a result of mass reduction. 
agents used in the perioperative period (e.g., ni- 
trates,/3-agonists, phosphodiesterase inhibitors) will 
also have a profound impact on pulmonary wedge 
pressure. With these factors in mind, as pointed out 
previously, it is important o note that because 
multiple factors can influence pulmonary capillary 
wedge pressure, a decrease in this parameter does 
not necessarily indicate an improvement in heart 
function. 2 
The results presented in this study have been 
derived by means of an analytic approach. Accord- 
ingly, the validity of the interpretations depend on 
the validity of the assumptions underlying the anal- 
ysis. It is unlikely that the myocardium is truly 
homogeneous in terms of thickness and function, 
and therefore the resulting properties of the nonex- 
cised portion may not simply relate to the volume of 
the compartment excised, as was assumed. In addi- 
tion to assumptions detailed in the Methods and 
materials section, we assumed that there was no 
alteration in myocardial function caused by the 
presence of a suture line. However, most of the basic 
aspects have been tested and validated in multiple 
experimental models. 7 Also, as noted earlier, similar 
analytic approaches have been used successfully in
the past by one group of investigators tostudy other 
complex hemodynamic phenomena involving inter- 
actions between the heart and vasculature. 2-4Addi- 
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tionally, results of our finite element analysis reveal 
the same changes in ESPVR and EDPVR as were 
found with the multicompartment model; concor- 
dance between these two different methods upports 
the validity of the results. Nevertheless, the results 
should be viewed as providing qualitative insights 
that are subject o verification. It is not the intention 
of such an analysis to provide detailed quantitative 
predictions of clinical scenarios, because ach pa- 
tient profile will vary significantly. The utility of this 
type of analysis is clear, however, particularly when 
so little detailed information is available from either 
experimental or clinical settings. Also, it will be a 
challenge to create an appropriate animal model 
with which to obtain such information. The rapid 
cardiac pacing model used in dogs and pigs has the 
disadvantage that a significant amount of function 
recovers once pacing is stopped. The coronary mi- 
croembolization model might be useful, but the 
degree of ventricular dysfunction seen in that model 
(with ejection fractions typically about 30%) does 
not approach the degree of dysfunction seen in 
patients who are receiving this therapy (with ejec- 
tion fractions well below 20%). 16 
In summary, the results of the present analysis 
reveal that improvements in ejection fraction, end- 
systolic elastance, and preload recruitable stroke 
work after ventricular mass reduction surgery have 
different implications than when such changes are 
observed with inotropy resulting from acute phar- 
macologic therapy. This difference stems predomi- 
nantly from the fact that mass reduction will cause 
changes in diastolic ventricular properties, and con- 
sequently overall pump function (the Frank-Starling 
relationship) does not improve as would be ob- 
served with a purely inotropic intervention. On the 
other hand, the geometric rearrangement leads to a 
reduction in wall stress for a given level of pressure 
generation, thus implying an increase in the effi- 
ciency with which wall stress is transduced into 
intraventricular pressure. Whether this may trans- 
late into long-term benefits depends, in part, on the 
degree of aftertoad reduction that is maintained and 
in part on whether the underlying pathophysiologic 
process that led to the cardiomyopathy in the first 
place continues to progress. Finally, several other 
incidental factors associated with the procedure may 
contribute to clinical benefits of ventricular mass 
reduction (e.g., concomitant mitral annuloplasty, 
perioperative pharmacologic and fluid manage- 
ment). Results of ongoing clinical trials will establish 
whether this procedure truly offers sustained benefit 
to patients with end-stage cardiomyopathy; how- 
ever, it will be equally important to study the 
underlying physiology of this procedure. Such un- 
derstanding may ultimately contribute to devising 
appropriate patient selection criteria, tailoring the 
surgical procedure (e.g., how much muscle should 
be removed), and helping guide future research 
efforts aimed at optimizing the effects of this novel 
form of therapy. In this regard, the results of the 
present analysis provide a strong foundation for 
such efforts. 
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Appendix 
Relation between mass removed and chamber volume. 
The LV was modeled as rotationally symmetric, hemi- 
elliptic chamber, with short-axis radius at the base Rs, 
long-axis length of L (the length from the base to the 
apex), and uniform wall thickness T w. Heart reduction was 
assumed to remove a wedge-shaped portion of myocar- 
dium such that R s decreased while leaving starting Tw and 
L unchanged. The value for L was 9 cm, and the starting 
values for Tw and R s were 1.5 cm and 3.8 cm, respec- 
tively. LV chamber volume (VLv) was calculated as: 
VLV = 0.5 × 4/3 ~r L ( is)  2 (9) 
For the baseline condition (before mass reduction, Rs = 
3.8 cm); VLv therefore equaled 270 ml. As R s was 
decreased, the chamber volume decreased in a nonlinear 
fashion. The coefficient of chamber volume reduction (r) 
is calculated by means of the formula: 
r = (270 - VLv)/270 (10) 
LV wall volume (Vw) was calculated according to the 
following equation: 
Vw = (0.5 × 4/3~r [L + Tw][Rs + Tw] 2) - VLV 
(11) 
LV wall mass (MLv) was calculated as the product of 
myocardial wall density (0.96) and Vw • The mass 
excised (Mx) varied with the reduction in R s and was 
calculated by combining equations 7 and 9 and solving 
numerically. 
Cardiovascular simulation. The set of equations used 
to simulate the entire cardiovascular system has been fully 
described in previous publications. 2-4The RV and LV 
were coupled to pulmonary and systemic arterial and 
venous vascular beds; these beds were composed of a 
proximal characteristic resistance, an arterial resistance, a 
venous resistance, and venous and arterial compliances. 
The value of each parameter of the model (Appendix 
Table I) was set to be appropriate for a 75 kg man with 
dilated cardiomyopathy. Stressed blood volume was ini- 
tially set at 3000 ml and was reduced in increments of 250 
ml to vary preload. 
Finite element analysis. The purpose of this finite 
element analysis is to provide a second and independent 
analytic method of determining the effect of mass reduc- 
tion on pressure-volume relations. ESPVRs and EDPVRs 
were determined assuming the same hemielliptic model 
described earlier. At each level of mass reduction, the 
relationship between R s and T w was calculated from 
Appendix Table I. Parameter values for 
vasculature, right and left ventricles, which were 
chosen to be appropriate for a 70 kg man with 
dilated cardiomyopathy 
Vascular parameters Pulmonary Systemic 
Arterial resistance (Wood units) 1.0 15.5 
Characteristic resistance (Wood units) 0.3 0.3 
Venous resistance (Wood units) 0.25 0.25 
Arterial capacitance (ml. mm Hg -I) 13 1.3 
Venous capacitance (mt • mm Hg 1) 8 150 
Heart function parameters RV LV 
Maximum elastance (mm Hg - m1-1) 0.3 0.5 
Unstressed volume (ml) 10 50 
Time to end-systole (mse¢) 175 175 
Time constant of relaxation (msec) 25 25 
Scaling factor for EDPVR (mm Hg) 0.13 0.16 
Exponent for EDPVR (K, ml 1) 0.019 0.024 
Heart rate (beats/min) 75 75 
equation 11. The midwall circumference (Crow) is then 
calculated as 
Crow = 0.5 × 4/3 ~- L (Rs + 0.5Tw) 2 (12) 
Midwall strain (e) at the base is given by 
= (Cmw - Cmwo)/(Cmwmax - CmwO ) (13) 
where Cmwo is the midwall circumference when chamber 
volume quals Vo, and Cmwmax isthe circumference orre- 
sponding to the starting chamber volume. Average stress (~) 
is then calculated according to empiric functions for systole 
and diastole: 
o- = 160 e 25 at end-systole (14) 
cr = 60 e 7 at end-diastole (15) 
The particular parameters for systolic and diastolic stress 
were chosen to approximate the ESPVR and EDPVR 
used in the multicompartment model and represent the 
elemental myocardial properties used in this analysis. LV 
pressure (PLv) is calculated as 
PLV = Aw (r/A~h (16) 
where A~v , the long-axis myocardial cross-sectional area, is 
given by 
Aw = 0.5 ~r ([Rs + Twl[L + Tw] - Rs L) (17) 
and Ach , the long-axis chamber cross-sectional rea, is 
given by 
Ach : 0.5 7rRs L (18) 
Because LV volume (equation 9) and LV pressure 
(equation 16) are both functions of Rs, pressure- 
volume relationships are thus calculated over a range of 
1040 Dickstein et al. 
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Appendix Fig. 1. Left ventricular pressure-volume relations determined from finite element analysis at each 
of the four levels of mass reduction (0 gin, solid line; 25 gin, dotted line; 50 gin, dashed line; 75 gin, 
dotted~dashed line). As mass is reduced from 0 to 75 gin, the ESPVR slope and curvature of the EDPVR 
both increase; these changes are similar to that shown in Fig. 2 derived from compartmental modeling. 
chamber volumes by varying R s. Heart reduction was 
assumed to reduce myocardial mass, while leaving 
myocardial stress-strain relations (equations 14 and 15) 
and starting Tw unchanged. ESPVRs and EDPVRs 
thus determined are illustrated in Appendix Fig. 1. 
Similar to the multicompartment model, this finite 
element analysis shows that mass reduction causes 
equivalent shifts in the ESPVRs and EDPVRs. 
Commentary 
Although the ventricular eduction operation for di- 
lated cardiomyopathy as received tremendous attention 
in the lay press and in a few medical publications, the 
physiologic basis of this procedure has not been com- 
pletely established either in the laboratory or in clinical 
settings. In particular, the relative importance of mitral 
valve repair versus ventricular resection is unclear. The 
more practical issue of how much myocardium to 
remove is addressed in the article by Dickstein and 
associates. The authors used a multiple compartment 
elastance model to demonstrate hat increasing removal 
of up to 75 gm of myocardium caused progressive 
increase in left ventricular contractility (measured by 
end-systolic elastance), increase in left ventricular ejec- 
tion fraction, and decrease in left ventricular end- 
diastolic volume. These improvements were at the 
expense of decreased stroke volume, decreased ventric- 
ular diastolic compliance, and a small decrease m left 
ventricular systolic pressure. Thus, as with left ventric- 
ular aneurysmectomy, excesswe ventricular esection 
can result in patient morbidity and even death because 
of the inability to maintain an acceptable cardiac output 
without excessive pulmonary venous pressure or exces- 
sive heart rate. 
Dickstein and associates provide a foundation to ad- 
dress two remaining questions facing the surgeon who 
considers a ventricular reduction operation. 
1. How can it be demonstrated whether a given patient 
has sufficient intrinsic myocardial contractility to benefit 
from ventricular reduction? 
2. What is the optimal volume of myocardium to resect 
in a given patient to obtain maximal benefit without 
excessive reduction in stroke volume or excessive increase 
in pulmonary venous pressure? 
Answer to these questions will await quantitative work 
like that of Dickstein and associates, both in the animal 
laboratory and in thoughtful clinical studies. 
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